Eritoran
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Eritoran, covering 2014-07-11 to 2014-07-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors [Phase 1]